Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


03.04.2017

1 Acta Neuropathol
5 Alzheimers Dement
1 Am J Alzheimers Dis Other Demen
1 Biol Psychiatry
2 Curr Alzheimer Res
1 Dement Geriatr Cogn Disord
1 J Alzheimers Dis
1 J Neurosci
1 Lancet Psychiatry
1 Nat Rev Neurol
2 Neurobiol Aging
1 Neurobiol Dis
1 Neurosci Lett
3 PLoS Med
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. DURAN-ANIOTZ C, Cornejo VH, Espinoza S, Ardiles AO, et al
    IRE1 signaling exacerbates Alzheimer's disease pathogenesis.
    Acta Neuropathol. 2017 Mar 24. doi: 10.1007/s00401-017-1694.
    PubMed     Text format     Abstract available


    Alzheimers Dement

  2. NIELSEN RB, Egefjord L, Angleys H, Mouridsen K, et al
    Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 23. pii: S1552-5260(17)30092.
    PubMed     Text format     Abstract available

  3. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Alzheimers Dement. 2017 Mar 22. pii: S1552-5260(16)33124.
    PubMed     Text format     Abstract available

  4. ROCKWOOD K, Howlett SE, Hoffman D, Schindler R, et al
    Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30090.
    PubMed     Text format     Abstract available

  5. HERUKKA SK, Simonsen AH, Andreasen N, Baldeiras I, et al
    Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.
    Alzheimers Dement. 2017;13:285-295.
    PubMed     Text format     Abstract available

  6. TOLEDO JB, Arnold M, Kastenmuller G, Chang R, et al
    Metabolic network failures in Alzheimer's disease-A biochemical road map.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30046.
    PubMed     Text format     Abstract available


    Am J Alzheimers Dis Other Demen

  7. YANG YH, Meguro K, Dominguez J, Chen CL, et al
    Gender's Effects to the Early Symptoms of Alzheimer's Disease in 5 Asian Countries.
    Am J Alzheimers Dis Other Demen. 2017 Jan 1:1533317517698796.
    PubMed     Text format     Abstract available


    Biol Psychiatry

  8. SHEN Y, Wang H, Sun Q, Yao H, et al
    Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
    Biol Psychiatry. 2017 Mar 27. pii: S0006-3223(17)30098.
    PubMed     Text format     Abstract available


    Curr Alzheimer Res

  9. SHARIFLOU S, Georgevsky D, Mansour H, Rezaeian M, et al
    Diagnostic and prognostic potential of retinal biomarkers in early on-set Alzheimer`s disease.
    Curr Alzheimer Res. 2017 Mar 29. doi: 10.2174/1567205014666170329114445.
    PubMed     Text format     Abstract available

  10. ECHEVERRIA V, Barreto GE, Avila-Rodriguez M, Tarasov VV, et al
    Is VEGF a key target of cotinine and other potential therapies against Alzheimer disease?
    Curr Alzheimer Res. 2017 Mar 29. doi: 10.2174/1567205014666170329113007.
    PubMed     Text format     Abstract available


    Dement Geriatr Cogn Disord

  11. BALACHANDAR R, Bharath S, John JP, Joshi H, et al
    Resting-State Functional Connectivity Changes Associated with Visuospatial Cognitive Deficits in Patients with Mild Alzheimer Disease.
    Dement Geriatr Cogn Disord. 2017;43.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  12. LIU XJ, Wei J, Shang YH, Huang HC, et al
    Modulation of AbetaPP and GSK3beta by Endoplasmic Reticulum Stress and Involvement in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Mar 20. doi: 10.3233/JAD-161111.
    PubMed     Text format     Abstract available


    J Neurosci

  13. GRATTON C, Yousef S, Aarts E, Wallace DL, et al
    Cholinergic, but not dopaminergic or noradrenergic, enhancement sharpens visual spatial perception in humans.
    J Neurosci. 2017 Mar 23. pii: 2405-16. doi: 10.1523/JNEUROSCI.2405-16.2017.
    PubMed     Text format     Abstract available


    Lancet Psychiatry

  14. MILNE R, Karlawish J
    Expanding engagement with the ethical implications of changing definitions of Alzheimer's disease.
    Lancet Psychiatry. 2017;4:e6-e7.
    PubMed     Text format    


    Nat Rev Neurol

  15. WOOD H
    Alzheimer disease: Localized proteomics distinguishes AD subtypes.
    Nat Rev Neurol. 2017 Mar 24. doi: 10.1038/nrneurol.2017.
    PubMed     Text format    


    Neurobiol Aging

  16. CHUNG SJ, Kim MJ, Ryu HS, Kim J, et al
    Lack of association of mortalin (HSPA9) and other mitochondria-related genes with risk of Parkinson's and Alzheimer's diseases.
    Neurobiol Aging. 2017;49:215.
    PubMed     Text format     Abstract available

  17. COLIN J, Thomas MH, Gregory-Pauron L, Pincon A, et al
    Maintenance of membrane organization in the aging mouse brain as the determining factor for preventing receptor dysfunction and for improving response to anti-Alzheimer treatments.
    Neurobiol Aging. 2017;54:84-93.
    PubMed     Text format     Abstract available


    Neurobiol Dis

  18. CONDELLO C, Stohr J
    Abeta propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease.
    Neurobiol Dis. 2017 Mar 27. pii: S0969-9961(17)30062.
    PubMed     Text format     Abstract available


    Neurosci Lett

  19. JIANG S, Yan C, Qiao Z, Yao H, et al
    Mismatch negativity as a potential neurobiological marker of early-stage Alzheimer disease and vascular dementia.
    Neurosci Lett. 2017;647:26-31.
    PubMed     Text format     Abstract available


    PLoS Med


  20. Correction: Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.
    PLoS Med. 2017;14:e1002289.
    PubMed     Text format     Abstract available

  21. STEELE NZ, Carr JS, Bonham LW, Geier EG, et al
    Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case-control study.
    PLoS Med. 2017;14:e1002272.
    PubMed     Text format     Abstract available

  22. LANOISELEE HM, Nicolas G, Wallon D, Rovelet-Lecrux A, et al
    APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    PLoS Med. 2017;14:e1002270.
    PubMed     Text format     Abstract available


    PLoS One

  23. LIANG CT, Huang HB, Wang CC, Chen YR, et al
    L17A/F19A Substitutions Augment the alpha-Helicity of beta-Amyloid Peptide Discordant Segment.
    PLoS One. 2016;11:e0154327.
    PubMed     Text format     Abstract available

  24. LIN TW, Chang CF, Chang YJ, Liao YH, et al
    Alzheimer's amyloid-beta A2T variant and its N-terminal peptides inhibit amyloid-beta fibrillization and rescue the induced cytotoxicity.
    PLoS One. 2017;12:e0174561.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  25. WANG BJ, Her GM, Hu MK, Chen YW, et al
    ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2017 Mar 28. pii: 201618804.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: